Hooman Hakami Medtronic PLC (MDT) insider trading activity

Hooman Hakami is EVP & Group President Diabetes of Medtronic plc. Currently has a direct ownership of 30,761 shares of MDT, which is worth approximately $2.71 Million. The most recent transaction as insider was on Sep 10, 2019, when has been sold 82,877 shares (Ordinary Shares) at a price of $107.26 per share, resulting in proceeds of $8,889,387. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K

0% 3M change

0% 12M change

Total Value Held $2.71 Million

HOOMAN HAKAMI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2019	SELL Open market or private sale	$8,889,387 $107.26 p/Share	82,877 Reduced 72.93%	30,761 Ordinary Shares
Sep 10 2019	BUY Exercise of conversion of derivative security	$6,178,512 $84.78 p/Share	72,877 Added 70.03%	31,184 Ordinary Shares
Aug 01 2019	SELL Payment of exercise price or tax liability	$1,050,828 $102.37 p/Share	10,265 Reduced 20.12%	40,761 Ordinary Shares
Jul 29 2019	BUY Grant, award, or other acquisition	-	8,071 Added 13.66%	51,026 Ordinary Shares
Jun 12 2019	SELL Open market or private sale	$5,134,213 $97.49 p/Share	52,664 Reduced 55.24%	42,673 Ordinary Shares
Jun 12 2019	BUY Exercise of conversion of derivative security	$2,475,018 $78.0 p/Share	31,731 Added 24.97%	95,337 Ordinary Shares
Aug 31 2018	SELL Open market or private sale	$2,518,850 $96.29 p/Share	26,159 Reduced 29.46%	62,647 Ordinary Shares
Aug 31 2018	BUY Exercise of conversion of derivative security	$1,641,739 $62.76 p/Share	26,159 Added 22.75%	88,806 Ordinary Shares
Aug 03 2018	SELL Payment of exercise price or tax liability	$436,295 $90.48 p/Share	4,822 Reduced 7.15%	62,647 Ordinary Shares
Jul 30 2018	BUY Grant, award, or other acquisition	-	9,355 Added 12.34%	66,472 Ordinary Shares
Jul 28 2018	SELL Payment of exercise price or tax liability	$889,969 $88.66 p/Share	10,038 Reduced 14.95%	57,117 Ordinary Shares
Jan 05 2018	SELL Open market or private sale	$2,223,430 $85.0 p/Share	26,158 Reduced 28.44%	65,828 Ordinary Shares
Jan 05 2018	BUY Exercise of conversion of derivative security	$1,641,676 $62.76 p/Share	26,158 Added 22.14%	91,986 Ordinary Shares
Jul 31 2017	BUY Grant, award, or other acquisition	-	9,528 Added 12.7%	65,473 Ordinary Shares
Jul 28 2017	SELL Payment of exercise price or tax liability	$329,911 $84.29 p/Share	3,914 Reduced 6.54%	55,945 Ordinary Shares
Mar 02 2017	SELL Open market or private sale	$4,307,176 $82.33 p/Share	52,316 Reduced 47.03%	58,929 Ordinary Shares
Mar 02 2017	BUY Exercise of conversion of derivative security	$3,283,352 $62.76 p/Share	52,316 Added 31.99%	111,245 Ordinary Shares
Aug 01 2016	BUY Grant, award, or other acquisition	-	20,441 Added 25.96%	58,302 Ordinary Shares
Aug 03 2015	BUY Grant, award, or other acquisition	-	10,257 Added 21.8%	36,802 Ordinary Shares
Jan 26 2015	BUY Grant, award, or other acquisition	-	25,987 Added 50.0%	25,987 Ordinary Shares
Jan 26 2015	BUY Grant, award, or other acquisition	-	25,987 Added 50.0%	25,987 Ordinary Shares

Hooman Hakami

EVP & Group President Diabetes

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDT shares.

Notify only if

Value

Insider Trading

Get notified when an Medtronic PLC insider buys or sells MDT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Medtronic plc

Track Activities on MDT

Account